Two prominent hospital research labs in Ontario, Canada, have come under scrutiny after it was revealed that they sourced research dogs from a U.S. breeder with a concerning history of animal care violations. The University Health Network (UHN) in Toronto, although claiming to have ceased using dogs for research, and the Lawson Health Research Institute in London, Ontario, which recently terminated its dog testing program, previously purchased animals from Marshall BioResources. This U.S. facility has been repeatedly flagged by inspectors for a range of issues, including providing inadequate living conditions for the animals they breed.

Marshall BioResources, an industrial-scale breeding operation located in upstate New York, has faced numerous citations for mistreatment of animals over a span of several years. Reports from federal inspectors indicate serious infractions such as injuries and untreated sores on animals, moldy food, and unsanitary living conditions, with inspectors documenting 11 separate violations involving various dogs and cats between 2021 and 2024. This troubling record has amplified calls from both scientists and lawmakers to rethink the necessity of animal experimentation in scientific research.

The controversy surrounding the use of animals in research continues to gain traction as ethical concerns heighten, particularly regarding the sourcing and treatment of these animals. The involvement of well-respected institutions like UHN and Lawson in procuring dogs from a discredited breeder draws attention to the broader implications for animal welfare and ethical research standards. As public awareness grows, pressure mounts on laboratories to reconsider their research practices and to adopt more humane methodologies that do not rely on animal testing.